Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Leukoc Biol ; 75(6): 1079-85, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15020650

RESUMO

Monocyte chemoattractant protein-1 (MCP-1, CCL2) is a mediator of inflammation that has been implicated in the pathogenesis of a wide variety of human diseases. CCR2, a heterotrimeric G-coupled receptor, is the only known receptor that functions at physiologic concentrations of MCP-1. Despite the importance of CCR2 in mediating MCP-1 responses, several recent studies have suggested that there may be another functional MCP-1 receptor. Using arterial smooth muscle cells (SMC) from CCR2(-/-) mice, we demonstrate that MCP-1 induces tissue-factor activity at physiologic concentrations. The induction of tissue factor by MCP-1 is blocked by pertussis toxin and 1,2-bis(O-aminophenyl-ethane-ethan)-N,N,N',N'-tetraacetic acid-acetoxymethyl ester, suggesting that signal transduction through the alternative receptor is G(alphai)-coupled and dependent on mobilization of intracellular Ca(2+). MCP-1 induces a time- and concentration-dependent phosphorylation of the mitogen-activated protein kinases p42/44. The induction of tissue factor activity by MCP-1 is blocked by PD98059, an inhibitor of p42/44 activation, but not by SB203580, a selective p38 inhibitor. These data establish that SMC possess an alternative MCP-1 receptor that signals at concentrations of MCP-1 that are similar to those that activate CCR2. This alternative receptor may be important in mediating some of the effects of MCP-1 in atherosclerotic arteries and in other inflammatory processes.


Assuntos
Quimiocina CCL2/farmacologia , Monócitos/efeitos dos fármacos , Músculo Liso Vascular/metabolismo , Receptores de Quimiocinas/fisiologia , Transdução de Sinais , Animais , Aorta , Cálcio/metabolismo , Células Cultivadas , Inibidores Enzimáticos/farmacologia , Subunidades alfa Gi-Go de Proteínas de Ligação ao GTP/metabolismo , Homozigoto , Camundongos , Camundongos Knockout , Proteína Quinase 1 Ativada por Mitógeno/antagonistas & inibidores , Proteína Quinase 1 Ativada por Mitógeno/metabolismo , Proteína Quinase 3 Ativada por Mitógeno , Proteínas Quinases Ativadas por Mitógeno/antagonistas & inibidores , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Monócitos/metabolismo , Músculo Liso Vascular/efeitos dos fármacos , Toxina Pertussis/farmacologia , Fosforilação , Receptores CCR2 , Receptores de Quimiocinas/genética , Receptores de Quimiocinas/metabolismo , Proteínas Recombinantes/metabolismo , Tromboplastina/metabolismo , Proteínas Quinases p38 Ativadas por Mitógeno
2.
Mil Med ; 167(5): 442-4, 2002 May.
Artigo em Inglês | MEDLINE | ID: mdl-12053858

RESUMO

OBJECTIVE: Examine the treatment course of a 4-year-old girl with oppositional defiant disorder, which developed in the context of her father's deployment to Bosnia. METHOD: A case report of the interventions made with this patient and her clinical outcomes. RESULTS: The patient's behavior improved substantially with regular therapy sessions and with a designated playtime with her mother. CONCLUSIONS: One possible cause of oppositional defiant disorder is a parent-child attachment deficit. In this case, the child's parents are both active duty service members and her father was deployed overseas. Young children have difficulty verbalizing feelings of loss and may respond behaviorally by exerting control over their immediate environment. Some children may respond to unstructured play sessions in which they are able to express feelings and gain some control in their interactions with adults.


Assuntos
Transtornos de Deficit da Atenção e do Comportamento Disruptivo/terapia , Constipação Intestinal/psicologia , Transtornos de Deficit da Atenção e do Comportamento Disruptivo/etiologia , Transtornos do Comportamento Infantil/etiologia , Pré-Escolar , Características da Família , Feminino , Humanos , Militares , Relações Mãe-Filho
3.
Int J Cancer ; 107(3): 407-15, 2003 Nov 10.
Artigo em Inglês | MEDLINE | ID: mdl-14506741

RESUMO

Infection of cervical keratinocytes by high-risk HPV is involved in the etiology of cervical carcinoma. Since viral products are immunogenic, development of cancer may require suppression of immune responses directed against infected epithelial cells. Many markers of host immune effector responses decrease as cervical intraepithelial neoplasia progresses. Among these is epithelial cell expression of the chemokine MCP-1, though the mechanism for its suppression is unclear. Here, we show that the E6 and E7 viral oncogenes from high-risk HPV, individually and together, suppress MCP-1 expression in primary epithelial cells derived from the female genital tract. This is not a consequence of global suppression of chemokine expression since other chemokines, including IP-10, IL-8 and RANTES, were less affected. Furthermore, 4 of 6 HPV-positive cervical carcinoma cell lines did not express MCP-1. Our data indicate that suppression of MCP-1 expression is part of the program of high-risk HPV E6/E7-induced transformation of primary epithelial cells. These observations are consistent with a model in which MCP-1 expression by infected keratinocytes, which would stimulate an immune attack on HPV-transformed cells, is suppressed for invasive cervical cancer to appear.


Assuntos
Colo do Útero/imunologia , Quimiocina CCL2/antagonistas & inibidores , Queratinócitos/imunologia , Proteínas Oncogênicas Virais/fisiologia , Proteínas Repressoras , Neoplasias do Colo do Útero/imunologia , Células Cultivadas , Colo do Útero/virologia , Quimiocina CCL2/análise , Quimiocinas/análise , Células Epiteliais/imunologia , Feminino , Humanos , Queratinócitos/virologia , Papillomaviridae/patogenicidade , Proteínas E7 de Papillomavirus , Fatores de Tempo , Células Tumorais Cultivadas , Neoplasias do Colo do Útero/virologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA